Pharmacokinetics of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat and dog-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat and dog

Published:2004-10 Issue:10 Volume:34 Page:901-915
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

McKillop D.,Partridge E. A.,Hutchison M.,Rhead S. A.,Parry A. C.,Bardsley J.,Woodman H. M.,Swaisland H. C.

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/00498250400009189

Reference23 articles.

1. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: Extrapolation of data to benzodiazepines and phenytoin

2. Anti-epidermal growth factor receptor drugs in cancer therapy

3. Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

4. Pharmacologically Guided Phase I Clinical Trials Based Upon Preclinical Drug Development

5. Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of pharmacolipidodynamic effects following the intravenous and oral administration of gefitinib to C57Bl/6JRj mice by rapid UHPLC-MS analysis of plasma;Scientific Reports;2024-07-24

2. Discovery of YS-363 as a highly potent, selective, and orally eﬃcacious EGFR inhibitor;Biomedicine & Pharmacotherapy;2023-11

3. Detection of Pharmacolipidodynamic Effects Following the Intravenous and Oral Administration of Gefitinib to C57Bl/6JRj Mice by Rapid UHPLC/MS Analysis of Plasma;2023-10-04

4. Derivation of a new model of lung adenocarcinoma using canine lung cancer organoids for translational research in pulmonary medicine;Biomedicine & Pharmacotherapy;2023-09

5. Design and synthesis of gefitinib derivatives as potential drugs for cancer treatment: antiproliferative activity, molecular docking, and ADMET prediction;Letters in Drug Design & Discovery;2023-08-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3